STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

04.05.2012 20:08

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


1. Threadneedle Asset Management Holdings Limited

Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 1 May 2012, that on 26 April 2012 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.89% (570,727 shares). These voting
rights are attributable to Threadneedle Asset Management Holdings Limited
pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.


2. Threadneedle Asset Management Holdings SARL

Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has
notified us pursuant to sec. 21 para. 1 WpHG on 1 May 2012, that on 26
April 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE0007289001 went below the threshold of 5% and that the
percentage of voting rights on that day amounted to 4,94% (576,485 shares).
These voting rights are attributable to Threadneedle Asset Management
Holdings SARL pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with
sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
SARL inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.


3. Ameriprise Financial, Inc.

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 1 May 2012, that on 26 April 2012 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.99% (582,175 shares). These voting
rights are attributable to Ameriprise Financial, Inc. pursuant to sec. 22
para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.


4. Threadneedle Asset Management Limited

Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to sec. 21 para. 1 WpHG on 1 May 2012, that on 26 April 2012 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.89% (570,727 shares). These voting
rights are attributable to Threadneedle Asset Management Limited pursuant
to sec. 22 para. 1 sent. 1 no. 6.
The voting rights were attributed to Threadneedle Asset Management Limited
inter alia from Threadneedle Investment Funds ICVC, being a shareholder
holding 3% or more of the voting rights in STRATEC Biomedical AG.



04.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------